DOI: 10.1007/s13311-017-0540-0 Pages: 1-6
Article Type: Review

Antidepressant Actions of Ketamine Mediated by the Mechanistic Target of Rapamycin, Nitric Oxide, and Rheb

1. Johns Hopkins University School of Medicine, The Solomon H. Snyder Department of Neuroscience

2. Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences

3. Johns Hopkins University School of Medicine, Department of Pharmacology and Molecular Sciences

Correspondence to:
Solomon H. Snyder
Email: ssnyder@jhmi.edu

Close

Abstract

The weeks/months it takes for traditional antidepressants to act pose an obstacle in the management of depression. Ketamine’s prompt and sustained antidepressant effects constitute a major advance. Multiple studies implicate glutamatergic signaling to protein synthesis machinery and synapse formation in ketamine’s antidepressant effects. Here we review evidence linking ketamine to glutamate receptor subtypes and protein homeostasis. We describe a signaling cascade wherein nitric oxide drives the formation of a ternary protein complex comprised of glyceraldehyde 3-phosphate dehydrogenase, seven in absentia homolog 1, and Ras homolog enriched in brain downstream of the glutamate N-methyl-D-aspartate receptor. Seven in absentia homolog 1 ubiquitylates and degrades Ras homolog enriched in brain leading to inhibition of mechanistic target of rapamycin. Ketamine inhibits this molecular cascade leading to activation of mechanistic target of rapamycin and, in turn, to antidepressant actions.

To access the full text, please Sign in

If you have institutional access, please click here

  • Online: Jun 13, 2017

Article Tools